H.C. Wainwright lifts AnaptysBio stock target to $22, keeps Neutral
H.C. Wainwright analyst Emily Bodnar increased the price target on AnaptysBio (NASDAQ:ANAB) shares to $22.00, up from the previous $19.00, while maintaining a Neutral rating on the stock. According to ...
Hosted on MSN22h
AnaptysBio price target raised to $22 from $19 at H.C. Wainwright
H.C. Wainwright analyst Emily Bodnar raised the firm’s price target on AnaptysBio (ANAB) to $22 from $19 and keeps a Neutral rating on the shares ...
Medscape19h
Medication Review for the 10-Minute Consultation: The NO TEARS Tool
Geriatrics and Aging. 2005;8(6):43-45. Is the treatment still indicated or has the diagnosis been refuted? For example, a putative diagnosis of angina may have subsequently been disproved.
Greek Reporter19h
Greek news
A state of emergency has been declared on the Greek island of Amorgos in the southern Aegean Sea on Wednesday, February 12, as a string of earthquakes continues to rattle the region. Amorgos is the ...